Pharmacology of uricosuric drugs.
D000042:Absorption; D000818:Animals; D001001:Anura; D001692:Biological Transport / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D005919:Glomerular Filtration Rate; D000882:Haplorhini; D006801:Humans; D007684:Kidney Tubules / Q000378:metabolism; D002679:Pan troglodytes; D010653:Phenylbutazone / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use; D011485:Protein Binding; D051381:Rats; D011955:Receptors, Drug; D012459:Salicylates / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000494:pharmacology; D014527:Uric Acid / Q000378:metabolism; D014528:Uricosuric Agents / Q000009:adverse effects / Q000494:pharmacology*
D001798:Blood Proteins; D011955:Receptors, Drug; D012459:Salicylates; D014528:Uricosuric Agents; D014527:Uric Acid; D010653:Phenylbutazone; D011339:Probenecid; D013442:Sulfinpyrazone